Melanoctyic Lesions of the Vulva and Vagina

  • Thomas Brenn
  • Eduardo Calonje
Part of the Essentials of Diagnostic Gynecological Pathology book series (EDGP)


Pigmentary abnormalities of the lower female genital tract most commonly affect the vulva and only rarely the vagina. They are identified in about 10% of patients at routine gynecological examination and encompass melanocytic proliferations as well as non-melanocytic disorders including squamous lesions and inflammatory and reactive conditions. Only the true melanocytic proliferations as well as disorders characterized by hyperpigmentation are discussed in this chapter. The vast majority of pigmented lesions are benign, most frequently presenting as common acquired melanocytic nevi and genital lentigines/melanosis. In contrast, genital melanoma is a rare disease but early detection is crucial due to its poor prognosis at advanced stage. Its correct diagnosis may be challenging due to significant clinical and histological overlap with a subset of benign nevi, in particular the dysplastic and the atypical genital nevi. The salient clinical and histological features of these important entities are discussed in the appropriate context and with a particular focus on differential diagnosis.


Cytological Atypia Mucosal Melanoma Melanocytic Nevus Dysplastic Nevus Nodular Melanoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Mannone F, De Giorgi V, Cattaneo A, Massi D, De Magnis A, Carli P. Dermoscopic features of mucosal melanosis. Dermatol Surg. 2004;30(8):1118–23.PubMedCrossRefGoogle Scholar
  2. 2.
    Rock B. Pigmented lesions of the vulva. Dermatol Clin. 1992;10(2):361–70.PubMedGoogle Scholar
  3. 3.
    Ferrari A, Buccini P, Covello R, et al. The ringlike pattern in vulvar melanosis: a new dermoscopic clue for diagnosis. Arch Dermatol. 2008;144(8):1030–4.PubMedCrossRefGoogle Scholar
  4. 4.
    Ronger-Savle S, Julien V, Duru G, Raudrant D, Dalle S, Thomas L. Features of pigmented vulval lesions on dermoscopy. Br J Dermatol. 2011;164(1):54–61.PubMedCrossRefGoogle Scholar
  5. 5.
    Jackson R. Melanosis of the vulva. J Dermatol Surg Oncol. 1984;10(2):119–21.PubMedGoogle Scholar
  6. 6.
    Lenane P, Keane CO, Connell BO, Loughlin SO, Powell FC. Genital melanotic macules: clinical, histologic, immunohistochemical, and ultrastructural features. J Am Acad Dermatol. 2000;42(4):640–4.PubMedGoogle Scholar
  7. 7.
    Barnhill RL, Albert LS, Shama SK, Goldenhersh MA, Rhodes AR, Sober AJ. Genital lentiginosis: a clinical and histopathologic study. J Am Acad Dermatol. 1990;22(3):453–60.PubMedCrossRefGoogle Scholar
  8. 8.
    Sison-Torre EQ, Ackerman AB. Melanosis of the vulva. A clinical simulator of malignant melanoma. Am J Dermatopathol. 1985;7(Suppl):51–60.PubMedCrossRefGoogle Scholar
  9. 9.
    Kerley SW, Blute ML, Keeney GL. Multifocal malignant melanoma arising in vesicovaginal melanosis. Arch Pathol Lab Med. 1991;115(9):950–2.PubMedGoogle Scholar
  10. 10.
    Lee RB, Buttoni Jr L, Dhru K, Tamimi H. Malignant melanoma of the vagina: a case report of progression from preexisting melanosis. Gynecol Oncol. 1984;19(2):238–45.PubMedCrossRefGoogle Scholar
  11. 11.
    Kemmett D, Ellis J, Spencer MJ, Hunter JA. The Laugier-Hunziker syndrome – a clinical review of six cases. Clin Exp Dermatol. 1990;15(2):111–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Veraldi S, Cavicchini S, Benelli C, Gasparini G. Laugier-Hunziker syndrome: a clinical, histopathologic, and ultrastructural study of four cases and review of the literature. J Am Acad Dermatol. 1991;25(4):632–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Lenane P, Sullivan DO, Keane CO, Loughlint SO. The Laugier-Hunziker syndrome. J Eur Acad Dermatol Venereol. 2001;15(6):574–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Lampe AK, Hampton PJ, Woodford-Richens K, Tomlinson I, Lawrence CM, Douglas FS. Laugier-Hunziker syndrome: an important differential diagnosis for Peutz-Jeghers syndrome. J Med Genet. 2003;40(6):e77.PubMedCrossRefGoogle Scholar
  15. 15.
    Pandolfino TL, Cotell S, Katta R. Pigmented vulvar macules as a presenting feature of the Carney complex. Int J Dermatol. 2001;40(11):728–30.PubMedCrossRefGoogle Scholar
  16. 16.
    Rudolph RI. Vulvar melanosis. J Am Acad Dermatol. 1990;23(5 Pt 2):982–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Estrada R, Kaufman R. Benign vulvar melanosis. J Reprod Med. 1993;38(1):5–8.PubMedGoogle Scholar
  18. 18.
    Al-Shraim MM. Angiomatoid giant cellular blue nevus of vaginal wall associated with pregnancy. Diagn Pathol. 2011;6:32.PubMedCrossRefGoogle Scholar
  19. 19.
    Tobon H, Murphy AI. Benign blue nevus of the vagina. Cancer. 1977;40(6):3174–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Heim K, Hopfl R, Muller-Holzner E, Bergant A, Dapunt O. Multiple blue nevi of the vagina. A case report. J Reprod Med. 2000;45(1):42–4.PubMedGoogle Scholar
  21. 21.
    Ribe A. Melanocytic lesions of the genital area with attention given to atypical genital nevi. J Cutan Pathol. 2008;35 Suppl 2:24–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Polat M, Topcuoglu MA, Tahtaci Y, Hapa A, Yilmaz F. Spitz nevus of the genital mucosa. Indian J Dermatol Venereol Leprol. 2009;75(2):167–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Yamazhan M, Ertas IE, Kandiloglu G, Ozeren M. Cellular blue nevus of the vulva mimicking Bartholin’s gland abscess in a 15-year-old girl: a case report. Arch Gynecol Obstet. 2012;285:1009–11.PubMedCrossRefGoogle Scholar
  24. 24.
    Blickstein I, Feldberg E, Dgani R, Ben-Hur H, Czernobilsky B. Dysplastic vulvar nevi. Obstet Gynecol. 1991;78(5 Pt 2):968–70.PubMedGoogle Scholar
  25. 25.
    Elder DE. Precursors to melanoma and their mimics: nevi of special sites. Mod Pathol. 2006;19 Suppl 2:S4–20.PubMedCrossRefGoogle Scholar
  26. 26.
    Tucker MA, Halpern A, Holly EA, et al. Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA. 1997;277(18):1439–44.PubMedCrossRefGoogle Scholar
  27. 27.
    Halpern AC, Guerry Dt, Elder DE, Trock B, Synnestvedt M, Humphreys T. Natural history of dysplastic nevi. J Am Acad Dermatol. 1993;29(1):51–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Friedman RJ, Ackerman AB. Difficulties in the histologic diagnosis of melanocytic nevi on the vulvae of premenopausal women. In: Ackerman AB, editor. Pathology of malignant melanoma. New York: Masson; 1981. p. 119.Google Scholar
  29. 29.
    Hosler GA, Moresi JM, Barrett TL. Nevi with site-related atypia: a review of melanocytic nevi with atypical histologic features based on anatomic site. J Cutan Pathol. 2008;35(10):889–98.PubMedCrossRefGoogle Scholar
  30. 30.
    Christensen WN, Friedman KJ, Woodruff JD, Hood AF. Histologic characteristics of vulvar nevocellular nevi. J Cutan Pathol. 1987;14(2):87–91.PubMedCrossRefGoogle Scholar
  31. 31.
    Brenn T. Atypical genital nevus. Arch Pathol Lab Med. 2011;135(3):317–20.PubMedGoogle Scholar
  32. 32.
    Gleason BC, Hirsch MS, Nucci MR, et al. Atypical genital nevi. A clinicopathologic analysis of 56 cases. Am J Surg Pathol. 2008;32(1):51–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Clark Jr WH, Hood AF, Tucker MA, Jampel RM. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia. Hum Pathol. 1998;29(1 Suppl 1):S1–24.PubMedCrossRefGoogle Scholar
  34. 34.
    Carlson JA, Mu XC, Slominski A, et al. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol. 2002;138(1):77–87.PubMedCrossRefGoogle Scholar
  35. 35.
    Nguyen LP, Emley A, Wajapeyee N, Green MR, Mahalingam M. BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi. Br J Dermatol. 2010;162(3):677–80.PubMedCrossRefGoogle Scholar
  36. 36.
    Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerlof B, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival. Cancer. 1999;86(7):1285–93.PubMedCrossRefGoogle Scholar
  37. 37.
    Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol. 1994;171(5):1225–30.PubMedGoogle Scholar
  38. 38.
    Moxley KM, Fader AN, Rose PG, et al. Malignant melanoma of the vulva: an extension of cutaneous melanoma? Gynecol Oncol. 2011;122(3):612–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Stang A, Streller B, Eisinger B, Jockel KH. Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol. 2005;96(1):216–21.PubMedCrossRefGoogle Scholar
  40. 40.
    Raber G, Mempel V, Jackisch C, et al. Malignant melanoma of the vulva. Report of 89 patients. Cancer. 1996;78(11):2353–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS. Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol. 2007;110(2 Pt 1):296–301.PubMedCrossRefGoogle Scholar
  42. 42.
    Egan CA, Bradley RR, Logsdon VK, Summers BK, Hunter GR, Vanderhooft SL. Vulvar melanoma in childhood. Arch Dermatol. 1997;133(3):345–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Hu DN, Yu GP, McCormick SA. Population-based incidence of vulvar and vaginal melanoma in various races and ethnic groups with comparisons to other site-specific melanomas. Melanoma Res. 2010;20(2):153–8.PubMedCrossRefGoogle Scholar
  44. 44.
    Moan J, Porojnicu AC, Dahlback A, Grant WB, Juzeniene A. Where the sun does not shine: is sunshine protective against melanoma of the vulva? J Photochem Photobiol B. 2010;101(2):179–83.PubMedCrossRefGoogle Scholar
  45. 45.
    Wechter ME, Gruber SB, Haefner HK, et al. Vulvar melanoma: a report of 20 cases and review of the literature. J Am Acad Dermatol. 2004;50(4):554–62.PubMedCrossRefGoogle Scholar
  46. 46.
    Ragnarsson-Olding BK, Kanter-Lewensohn LR, Lagerlof B, Nilsson BR, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer. 1999;86(7):1273–84.PubMedCrossRefGoogle Scholar
  47. 47.
    Verschraegen CF, Benjapibal M, Supakarapongkul W, et al. Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer. 2001;11(5):359–64.PubMedCrossRefGoogle Scholar
  48. 48.
    Raspagliesi F, Ditto A, Paladini D, et al. Prognostic indicators in melanoma of the vulva. Ann Surg Oncol. 2000;7(10):738–42.PubMedCrossRefGoogle Scholar
  49. 49.
    Bradgate MG, Rollason TP, McConkey CC, Powell J. Malignant melanoma of the vulva: a clinicopathological study of 50 women. Br J Obstet Gynaecol. 1990;97(2):124–33.PubMedCrossRefGoogle Scholar
  50. 50.
    Irvin Jr WP, Legallo RL, Stoler MH, Rice LW, Taylor Jr PT, Andersen WA. Vulvar melanoma: a retrospective analysis and literature review. Gynecol Oncol. 2001;83(3):457–65.PubMedCrossRefGoogle Scholar
  51. 51.
    Suwandinata FS, Bohle RM, Omwandho CA, Tinneberg HR, Gruessner SE. Management of vulvar melanoma and review of the literature. Eur J Gynaecol Oncol. 2007;28(3):220–4.PubMedGoogle Scholar
  52. 52.
    Trimble EL, Lewis Jr JL, Williams LL, et al. Management of vulvar melanoma. Gynecol Oncol. 1992;45(3):254–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Trifiro G, Travaini LL, Sanvito F, et al. Sentinel node detection by lymphoscintigraphy and sentinel lymph node biopsy in vulvar melanoma. Eur J Nucl Med Mol Imaging. 2010;37(4):736–41.PubMedCrossRefGoogle Scholar
  54. 54.
    Mulvany NJ, Sykes P. Desmoplastic melanoma of the vulva. Pathology. 1997;29(2):241–5.PubMedCrossRefGoogle Scholar
  55. 55.
    Creasman WT, Phillips JL, Menck HR. A survey of hospital management practices for vulvar melanoma. J Am Coll Surg. 1999;188(6):670–5.PubMedCrossRefGoogle Scholar
  56. 56.
    Frumovitz M, Etchepareborda M, Sun CC, et al. Primary malignant melanoma of the vagina. Obstet Gynecol. 2010;116(6):1358–65.PubMedCrossRefGoogle Scholar
  57. 57.
    Gupta D, Malpica A, Deavers MT, Silva EG. Vaginal melanoma: a clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 2002;26(11):1450–7.PubMedCrossRefGoogle Scholar
  58. 58.
    Borazjani G, Prem KA, Okagaki T, Twiggs LB, Adcock LL. Primary malignant melanoma of the vagina: a clinicopathological analysis of 10 cases. Gynecol Oncol. 1990;37(2):264–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U. Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960–1984. Cancer. 1993;71(5):1893–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Cobellis L, Calabrese E, Stefanon B, Raspagliesi F. Malignant melanoma of the vagina. A report of 15 cases. Eur J Gynaecol Oncol. 2000;21(3):295–7.PubMedGoogle Scholar
  61. 61.
    Edwards RH, Ward MR, Wu H, et al. Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet. 2004;41(4):270–2.PubMedCrossRefGoogle Scholar
  62. 62.
    Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135–47.PubMedCrossRefGoogle Scholar
  63. 63.
    Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol. 2003;163(5):1765–70.PubMedCrossRefGoogle Scholar
  64. 64.
    Yun J, Lee J, Jang J, et al. KIT amplification and gene mutations in acral/mucosal melanoma in Korea. APMIS. 2011;119(6):330–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24(26):4340–6.PubMedCrossRefGoogle Scholar
  66. 66.
    Omholt K, Grafstrom E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK. KIT pathway alterations in mucosal melanomas of the vulva and other sites. Clin Cancer Res. 2011;17(12):3933–42.PubMedCrossRefGoogle Scholar
  67. 67.
    Guo J, Si L, Kong Y, et al. Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol. 2011;29(21):2904–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Carvajal RD, Antonescu CR, Wolchok JD, et al. KIT as a therapeutic target in metastatic melanoma. JAMA. 2011;305(22):2327–34.PubMedCrossRefGoogle Scholar
  69. 69.
    Jiang X, Zhou J, Yuen NK, et al. Imatinib targeting of KIT-mutant oncoprotein in melanoma. Clin Cancer Res. 2008;14(23):7726–32.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Department of PathologyWestern General Hospital and The University of EdinburghEdinburghUK
  2. 2.Department of DermatopathologySt. John’s Institute of Dermatology, St. Thomas’ HospitalLondonUK

Personalised recommendations